|
|
|
Insider
Information: |
Fil Ltd |
Relationship: |
See Remark 1 |
City: |
Hamilton |
State: |
D0 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
6,389,934 |
|
Indirect Shares
|
1,682,059 |
|
|
Direct
Value |
$62,235,128 |
|
|
Indirect Value
|
$31,352,403 |
|
|
Total
Shares |
8,071,993 |
|
|
Total
Value |
$93,587,531 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ironwood Pharmaceuticals Inc |
IRWD |
Edward C. Johnson 3d, ... |
2011-03-29 |
2,450,111 |
2013-03-28 |
837,736 |
Premium* |
|
Cogent Biosciences, Inc. |
COGT |
See Remark 1 |
2018-04-03 |
1,138,274 |
2018-04-03 |
0 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
See Remark 1 |
2018-04-23 |
886,716 |
2018-04-23 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
See Remark 1 |
2017-12-12 |
1,914,833 |
2017-12-12 |
1,379 |
Premium* |
|
Xilio Therapeutics, Inc. |
XLO |
See Remark 1 |
2021-10-26 |
0 |
2021-10-26 |
218,705 |
Premium* |
|
Structure Therapeutics Inc. |
GPCR |
See Remark 1 |
2023-02-07 |
0 |
2023-02-07 |
624,239 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GPCR |
Structure Therapeutics In... |
See Remark 1 |
|
2023-02-07 |
4 |
A |
$0.00 |
$0 |
I/I |
6,473,761 |
624,239 |
0 |
- |
|
XLO |
Xilio Therapeutics, Inc. |
See Remark 1 |
|
2021-10-26 |
4 |
A |
$0.00 |
$0 |
I/I |
218,705 |
218,705 |
0 |
- |
|
SURF |
Surface Oncology, Inc. |
See Remark 1 |
|
2018-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
886,716 |
886,716 |
0 |
- |
|
COGT |
Cogent Biosciences, Inc. |
See Remark 1 |
|
2018-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,138,274 |
1,138,274 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
See Remark 1 |
|
2017-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,775,856 |
1,379 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
See Remark 1 |
|
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,497,951 |
1,914,833 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2013-03-28 |
4 |
S |
$18.40 |
$2,908,530 |
I/I |
(158,068) |
837,736 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2013-03-21 |
4 |
S |
$0.00 |
$0 |
I/I |
(240,100) |
995,804 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-15 |
4 |
S |
$13.13 |
$461,541 |
I/I |
(35,153) |
1,235,904 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-12 |
4 |
S |
$13.37 |
$1,580,743 |
I/I |
(118,220) |
1,271,057 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-11 |
4 |
S |
$13.08 |
$778,310 |
I/I |
(59,502) |
1,389,277 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-08 |
4 |
S |
$13.00 |
$76,432 |
I/I |
(5,878) |
1,448,779 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-05 |
4 |
S |
$13.02 |
$165,746 |
I/I |
(12,727) |
1,454,657 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-04 |
4 |
S |
$13.00 |
$9,100 |
I/I |
(700) |
1,467,384 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-03 |
4 |
S |
$13.00 |
$81,900 |
I/I |
(6,300) |
1,468,084 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-10-01 |
4 |
S |
$13.02 |
$27,333 |
I/I |
(2,100) |
1,474,384 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-27 |
4 |
S |
$13.24 |
$577,342 |
I/I |
(43,622) |
1,476,484 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-26 |
4 |
S |
$13.20 |
$674,363 |
I/I |
(51,073) |
1,520,106 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-25 |
4 |
S |
$13.88 |
$500,634 |
I/I |
(36,056) |
1,571,179 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-24 |
4 |
S |
$14.09 |
$1,133,011 |
I/I |
(80,409) |
1,607,235 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-21 |
4 |
S |
$14.89 |
$1,775,070 |
I/I |
(119,221) |
1,806,865 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-20 |
4 |
S |
$13.75 |
$733,613 |
I/I |
(53,342) |
1,806,865 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-19 |
4 |
S |
$13.34 |
$745,379 |
I/I |
(55,878) |
1,860,207 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-18 |
4 |
S |
$13.53 |
$664,317 |
I/I |
(49,113) |
1,916,085 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Edward C. Johnson 3d |
|
2012-09-17 |
4 |
S |
$13.22 |
$519,909 |
I/I |
(39,337) |
1,965,198 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|